Harmonised Q10 Q10 – Pharmaceutical Quality System Read More In Process Q10 Q10 – Pharmaceutical Quality System Read More Pre-harmonisation Q10 – Pharmaceutical Quality System Read More
Harmonised Q11 Q11 – Development and Manufacture of Drug Substances (Chemical Entities and Biotechnological/Biological Entities) Read More In Process Q11 Q11 – Development and Manufacture of Drug Substances (Chemical Entities and Biotechnological/Biological Entities) Read More Pre-harmonisation Q11 – Development and Manufacture of Drug Substances (Chemical Entities and Biotechnological/Biological Entities) Read More
Harmonised Q12 Q12 – Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management Read More In Process Q12 Q12 – Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management Read More Pre-harmonisation Q12 – Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management Read More
Harmonised Q13 Q13 – Continuous Manufacturing of Drug Substances and Drug Products Read More In Process Q13 Q13 – Continuous Manufacturing of Drug Substances and Drug Products Read More Pre-harmonisation Q13 – Continuous Manufacturing of Drug Substances and Drug Products Read More
Harmonised Q14 Q14 – Analytical Procedure Development Read More In Process Q14 Q14 – Analytical Procedure Development Read More Pre-harmonisation Q14 – Analytical Procedure Development Read More
Harmonised S1A S1A – Need for Carcinogenicity Studies of Pharmaceuticals Read More In Process S1A S1A – Need for Carcinogenicity Studies of Pharmaceuticals Read More Pre-harmonisation S1A – Need for Carcinogenicity Studies of Pharmaceuticals Read More
Harmonised S1B(R1) S1B – Testing for Carcinogenicity of Pharmaceuticals Read More In Process S1B(R1) S1B – Testing for Carcinogenicity of Pharmaceuticals Read More Pre-harmonisation S1B – Testing for Carcinogenicity of Pharmaceuticals Read More
Harmonised S1C(R2) S1C – Dose Selection for Carcinogenicity Studies of Pharmaceuticals Read More In Process S1C(R2) S1C – Dose Selection for Carcinogenicity Studies of Pharmaceuticals Read More Pre-harmonisation S1C – Dose Selection for Carcinogenicity Studies of Pharmaceuticals Read More
